SAFETY OF ADALIMUMAB IN GLOBAL CLINICAL TRIALS OF PATIENTS WITH CROHN?S DISEASE

(1) Centre Hospitalier, Universitaire de Lille, Lille, France

(2) University of Calgary, Calgary, Canada

(3) Mayo Clinic, Rochester, UnitedStates

(4) University Hospital ofGasthuisberg, Lueven, Belgium

(5) University of Chicago, Chicago, United States

(6) Medical University of Vienna, Vienna, Austria

(7) Abbott, Abbott Park, UnitedStates



This item was part of the Inflammatory Bowel Disease I session at UEG Week Barcelona 2010

This item can be cited as: Gut 2010; 59 (Suppl III) A191